Levin Michaelainsider trades

In SEC Form 4 filings, Levin Michaela is listed as Chief Business Officer of Acrivon Therapeutics, Inc. (ACRV). Levin Michaela reported no open-market purchases or sales in the last 90 days. The latest Form 4 transaction on record was filed on Sep 2.

Companies and roles

Company	Role	Transactions	Last filed
ACRVAcrivon Therapeutics, Inc.	Chief Business Officer	2	Sep 2

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-09-02

Company	Traded	Filed	Type	Shares	Price	Value	Owned after	10b5-1 plan	Filing
ACRVAcrivon Therapeutics, Inc.	Aug 31	Sep 2	A	30,000	$0.00	$0	30,000	No	Form 4
ACRVAcrivon Therapeutics, Inc.	Aug 31	Sep 2	A · derivative	130,000	$2.09	$271,700	130,000	No	Form 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.